HCA Virginia
August 27, 2020

Richmond, VA — HCA Virginia’s Henrico Doctors’ Hospital has become the first hospital in Central Virginia to perform a mitral valve repair for severe mitral regurgitation (MR), utilizing the latest MitraClip G4 system, a minimally-invasive treatment option for people with a severe leak in the mitral valve who are too high-risk for traditional open-heart surgery.

A leak in the mitral valve allows blood to flow back into the heart as it pumps. The heart has to work harder to keep blood flowing. This can raise the risk for life-threatening conditions like stroke and heart failure. When MR becomes severe, it can profoundly affect a person’s quality-of-life by causing shortness of breath, extreme fatigue, and other debilitating symptoms. If left untreated, MR can ultimately lead to heart failure and death.

The cardiology team at Henrico Doctors’ Hospital can now use the MitraClip G4 device, implanting the device through a small, minimally-invasive incision in the leg. The treatment works by clipping together portions of the leaflets, or flaps, of the mitral valve to reduce MR, which allows the heart to pump blood more efficiently, thereby relieving symptoms and improving a patient’s quality-of-life.

Patients tend to have a short hospital stay – on average, two days – and experience improved heart function almost immediately. The therapy has now treated over 100,000 patients worldwide.

Henrico Doctors’ Hospital also provides the most advanced treatment options available for patients suffering from severe aortic stenosis, a life-threatening condition caused by the buildup of calcium (i.e. mineral deposits) on the aortic valve’s leaflets. Through the innovative SAPIEN 3 Ultra valve platform, Henrico Doctors’ Hospital provides transcatheter aortic valve replacements for patients with severe aortic stenosis at low or greater risk for open-heart surgery.

Approximately 2.5 million people over the age of 75 suffer from this disease and the innovative technology and platform has proven to increase patients’ quality of life and avoid the risk of another open-heart procedure.

“This is a further advancement to allow us to help patients that have bad congestive heart failure or in simpler terms, problems breathing and fluid build-up due to leaky mitral valves that can’t be fixed with surgery,” said cardiologist Dr. Robert H. Levitt. “With these symptoms, surgery is not an option, and we’re proud to be the first in Richmond to perform this successful procedure.”

Cardiothoracic surgeon Dr. Graham Bundy said, “Keeping abreast of the latest in technological innovations such as the MitraClip and SAPIEN 3 Ultra valve platform ensures our patients are receiving the best treatment available. This helps us achieve our mission of putting the patient first and improving their quality of life.”